Structural Heart Devices Global Market

Forecast to 2022

Structural Heart Devices Global Market worth $8,792.0 million by 2022

IQ4I Research & Consultancy published a new report on Structural Heart Devices
Global Market Forecast To 2022 analyzes and studies the overall market, major
drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and
Rest of the World
IQ4Is Report Contains 67 market data tables and 36 figures spread through 233
pages and an exhaustive TOC on Structural Heart Devices Global Market [TYPE
{Repair (Annuloplasty, Valvuloplasty, Transcatheter Mitral Valve Repair (TMVR)),
Replacement (Surgical (Mechanical Valves and Biological/Tissue valves),
Transcatheter Aortic Valve Replacement (TAVR)}; END-USERS {Public and Private
Hospitals} Regional {North America, Europe, Asia Pacific and Rest of the World}]
This report analyzes the structural heart devices global market in terms of market revenue ($
million) for all segments and it enables Structural heart device manufacturers, Structural
heart device products distributors and wholesalers, Hospitals, OEM (Original Equipment
Manufacturers)/Contract manufacturers, Group Purchasing Organizations (GPOs)and other
associated stake holders to identify and analyze market expansion opportunities, upcoming
technologies, technological developments, competition in structural heart devices global
market.
Structural heart devices has emerged as a new focus area of medical device manufacturers
as the population of most developed and developing countries continue to become older and
risk of cardiovascular diseases increase with aging. The cardiovascular diseases which also
include structural heart diseases have become leading cause of death. It is projected that,
with newfound prosperity due to globalization and industrialization has led to changing
lifestyle increasing risk of younger people developing cardiovascular diseases. The
increased interest has led to development of new technologies and devices that are les s
invasive and address the need of treatment of patients who are considered too weak to
withstand the trauma of an open heart surgery. Structural heart devices market is expanding
at double digit rate, as estimated by IQ4I Research and Structural heart devices global
market is expected to reach $8,792.0 million by 2022.
Prevalence of heart valve diseases due to aging population, technological advancement and
growing healthcare expenditure and demand for minimally invasive surgery are driving
market growth.

However, strict regulatory requirements with high cost of device

IQ4I Research & Consultancy Pvt. Ltd.

Page 1

Structural Heart Devices Global Market

Forecast to 2022

development, lack of patient awareness and primary healthcare infrastructure in developing

countries, high cost associated with the device and procedure are hindering the growth of
market. The lack of properly trained professional who could use the advanced surgical
instruments is severely effecting development of the market.
The structural heart device global market is classified based on type, end-users and
geography. The structural heart device market by type is segmented into repair and
replacement markets base on the type of procedure performed. The repair segment is
further sub segmented into annuloplasty, valvuloplasty and Transcatheter mitral valve repair
(TMVR). The replacement segment is further segmented by technique into surgical valves
and Transcatheter aortic valves replacement (TAVR). The surgical valve is sub-segmented
as mechanical and tissue heart valves. The structural heart devices end-user market is
segmented into public and private hospitals based on location where the procedures are
performed. Finally, the structural heart devices market is classified by geographical regions
into North America, Europe, Asia-pacific and Rest of the World.
Geographical wise North America holds the largest share of the structural heart devices
global market followed by Europe. Enhanced government grants, launch of new products,
high healthcare budget allocation and increased interest in research and development are
the factors owing the growth of structural heart devices market in North American region.
Asia-Pacific region is considered to be the fastest growing market.
The major players operating in the structural heart device market are Edwards Lifesciences
Corporation (U.S.), Medtronic, PLC (Ireland), St. Jude Medical (U.S.), Abbott Laboratories
(U.S.), Liva Nova (U.K.), Boston Scientific Corporation (U.S.), Jenavalve GmbH (Germany),
CryoLife, Inc (U.S.), Lepu Medical (China) and Braile Biomedica, Ltda (Brazil).
Reasons for buying this report:

Identification and analysis of the structural heart devices market by identifying

various segments by type, end-user and geography.

Revenue forecast of the Structural heart devices market and strategic analysis of
each submarket with respect to segmental growth trends.

Identification of the major market trends and factors driving or inhibiting the growth of
the structural heart devices global market.

Revenue forecast of the structural heart devices market with respect to North
America, Europe, Asia-Pacific and the Rest of the World (RoW) regions.

IQ4I Research & Consultancy Pvt. Ltd.

Page 2

Structural Heart Devices Global Market

Forecast to 2022

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market.

Identification of key technology developments and innovations driving the market.

Profiles of major players in structural heart devices market with details of their
product offerings, revenues, business strategies, market shares and patent
application filing trend.

Established and Emerging players (51 companies) and their product offerings.
FIGURE 1
STRUCTURAL HEART DEVICES GLOBAL MARKET SEGMENTATION

Structural Heart Devices Global Market

Repair

Annuloplasty

Valvuloplasty

Replacement

TMVR

Surgical

TAVR

TMVR **

End-User

Region

Public
Hospitals
Private
Hospitals

North
America

Europe

Asia-Pacific

Mechanical

Biological

RoW

Request for more information

IQ4I Research & Consultancy Pvt. Ltd.

Page 3